Skip to main content

Celecoxib

NDC 77771-159 · Radha Pharmaceuticals, Inc.

Generic nameCelecoxib

Dosage formCAPSULE

RouteORAL

Active ingredient(s)CELECOXIB

Strength400 mg/1

Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]

Marketing categoryANDA

Packages

77771-159-60 — 60 CAPSULE in 1 BOTTLE (77771-159-60)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

76420-726 — Celecoxib, 76420-727 — Celecoxib, 76420-728 — Celecoxib, 76420-842 — Celecoxib, 76420-843 — Celecoxib, 76420-844 — Celecoxib, 76420-845 — Celecoxib, 77771-156 — Celecoxib, 77771-157 — Celecoxib, 77771-158 — Celecoxib, 80425-0037 — Celecoxib, 80425-0039 — Celecoxib, 80425-0040 — Celecoxib, 80425-0096 — Celecoxib, 80425-0142 — Celecoxib, 80425-0167 — Celecoxib, 80425-0209 — Celecoxib, 80425-0281 — Celecoxib, 80425-0321 — Celecoxib, 80425-0323 — Celecoxib, +213 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels